SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-19-000020
Filing Date
2019-08-08
Accepted
2019-08-08 16:50:11
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrxq22019.htm   iXBRL 10-Q 1419276
2 EXHIBIT 31.1 exhibit311q22019.htm EX-31.1 9698
3 EXHIBIT 31.2 exhibit312q22019.htm EX-31.2 9661
4 EXHIBIT 32.1 exhibit321q22019.htm EX-32.1 10012
  Complete submission text file 0000827871-19-000020.txt   6795012

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20190630.xsd EX-101.SCH 40706
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20190630_cal.xml EX-101.CAL 103670
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20190630_def.xml EX-101.DEF 205300
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20190630_lab.xml EX-101.LAB 614082
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20190630_pre.xml EX-101.PRE 364456
10 EXTRACTED XBRL INSTANCE DOCUMENT egrxq22019_htm.xml XML 1154111
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 191010267
SIC: 2834 Pharmaceutical Preparations